Literature DB >> 10845044

Improving the endoscopic view of the hypopharynx with anterior neck traction during the trumpet manoeuvre.

W Colquhoun-Flannery1, A Davis, J A Carruth.   

Abstract

The postcricoid subsite is difficult to visualize on flexible laryngopharyngoscopy. The view can be improved with either auto-insufflation manoeuvres or anterior neck skin traction. In this study, the view of the hypopharynx was graded whilst anterior neck skin traction was applied during the trumpet manoeuvre; the latter involves the patient blowing on his finger as if blowing up a balloon. On auto-insufflation alone, the postcricoid site was demonstrated in 22/25 (88 per cent) of cases and the upper oesophageal sphincter (UOS) in two out of 25 (eight per cent). Of the 22 cases in whom only the postcricoid site was demonstrated, subsequent neck skin traction revealed the UOS in eight. Overall, the use of auto-insufflation solely or in combination with traction resulted in UOS visualization in 40 per cent (10/25) of cases. The application of skin traction during trumpeting is easy to perform and should be used routinely.

Entities:  

Mesh:

Year:  2000        PMID: 10845044     DOI: 10.1258/0022215001905562

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Manoeuvres to Improve Endoscopic Visualization of Hypopharynx.

Authors:  Pooja Thakur; V K Poorey
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-12-26

2.  Enhancing Visibility of the Hypopharyngeal-Esophageal Region by Introduction of a Physiological Eructation Maneuver.

Authors:  Svetlana Politz; Martin Wagner; Degenhart Schwub; Sandra Cattenberg; Robert Thurnheer; Ludwig Schelosky
Journal:  Biomed Hub       Date:  2019-01-28

Review 3.  Phoniatricians and otorhinolaryngologists approaching oropharyngeal dysphagia: an update on FEES.

Authors:  Antonio Schindler; Laura W J Baijens; Ahmed Geneid; Nicole Pizzorni
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-15       Impact factor: 3.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.